227
Views
4
CrossRef citations to date
0
Altmetric
Pages 325-330 | Received 01 Apr 2015, Published online: 17 Dec 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Olga V. Marchenko. (2019) Commentary on “Statistics at FDA: Reflections on the Past Six Years”. Statistics in Biopharmaceutical Research 11:1, pages 17-19.
Read now
Erica Brittain, Dean Follmann & Gyan Joshi. (2018) Novel Superiority Tests for Anti-Infective Drug Trials: Three Examples. Statistics in Biopharmaceutical Research 10:1, pages 9-17.
Read now

Articles from other publishers (2)

Jean-François Timsit, Marlieke E. A. de Kraker, Harriet Sommer, Emmanuel Weiss, Esther Bettiol, Martin Wolkewitz, Stavros Nikolakopoulos, David Wilson & Stephan Harbarth. (2017) Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE’s STAT-Net. Intensive Care Medicine 43:7, pages 1002-1012.
Crossref
Harriet Sommer, Martin Wolkewitz & Martin Schumacher. (2017) The time-dependent “cure-death” model investigating two equally important endpoints simultaneously in trials treating high-risk patients with resistant pathogens. Pharmaceutical Statistics 16:4, pages 267-279.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.